StockMarketWire.com - PureTech Health said affiliate company resTORbio has a priced its initial public offering on the Nasdaq exchange.
Shares would be issued at an offer price of $15.00 each, resulting in gross proceeds of $85.0m.
Following the offering, PureTech Health would hold 9,800,396 shares of resTORbio common stock. At the initial public offering price of $15.00, those shares would have a value of $147.0m.
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.